Health TrialsbyHealthPanel

COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care

ConditionChildhood Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorStanford University

About this trial

This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Childhood cancer survivor previously treated with chemotherapy and/or radiation therapy

Currently age 18-25 years

Identifies as Hispanic/Latino

Currently ≥5 years post cancer diagnosis

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Family-Centered Communication Intervention

    Behavioral

    A novel family-centered communication intervention designed to facilitate communication among Young Adult Cancer Survivors (YA-CCS), their chosen support person, and clinicians through collaboration between the clinic and a community-based organization. The intervention includes pre-visit and post-visit sessions delivered by a community health worker and timed around a standard-of-care survivorship clinic visit.

Treatment groups

18 Participants
are divided into 1 treatment group
Group A: Family-Centered CommunicationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Proportion of invited young adult cancer survivor-support person dyads enrolled

Feasibility assessed by the proportion of invited dyads who enroll in the study.

Time frame
From recruitment initiation through completion of study enrollment, up to 24 months
2

Proportion of enrolled young adult cancer survivors completing all intervention components

Feasibility assessed by the proportion of enrolled young adult cancer survivor participants who complete all intervention components.

Time frame
From intervention initiation through intervention completion, up to 3 weeks
3

Mean Theoretical Framework of Acceptability questionnaire score

Acceptability assessed using participant-reported Theoretical Framework of Acceptability (TFA) questionnaire scores. Scores range from 1-5, with higher scores indicating greater acceptability.

Time frame
Post-intervention, within 2 months after intervention completion
4

Mean Satisfaction With Visit Preparation questionnaire score

Acceptability assessed using participant-reported Satisfaction With Visit Preparation questionnaire scores. Scores range from -10 to 10, with higher scores indicating greater satisfaction.

Time frame
Post-intervention, within 2 months after intervention completion

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Stanford University

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: